Home | Member Area

 Join the Roundtable
 About this Site
 Who We Are
 Call to Action
 Board of Directors
 Roundtable Update
 Reports & Studies
 Annual Conference
 Roundtable News
 Special Features

 Roundtable Policies
 Position Papers

 Tool Box
 Change Log-In
 Call or Write

Welcome to the Public Sector HealthCare Roundtable

About the Roundtable

Millions of Americans receive health care benefits as a result of their employment by state, county and local governmental units. The passage of the Affordable Care Act represents a historic opportunity to improve quality and increase value within the American health care system. However, the cost to provide this essential health care protection - to active and retired employees and to taxpayers - continues to increase at a challenging rate.

The Public Sector HealthCare Roundtable is a non-partisan, member-directed grassroots coalition that exists to give public employers and their health plan administrators a voice in this critical national discussion and to ensure that the public sector is not ignored in any federal action. As implementation of the Affordable Care Act continues, the Roundtable provides its members with a forum in which to share critical information and experiences and to consider potential partnerships that could improve efficiency and increase value.

Every public sector health care purchaser should consider joining today. For more information, visit our Join the Roundtable page.

Featured Resources
HealthCare Roundtable e-News - April 14, 2017
  • CMS Revises Rules for Exchanges
  • Trump Hints at Not Paying ACA Subsidies
  • Roundtable Member Weighs in on Biosimilar Interchangeability Guidance
  • Researchers Warn of Possibility of ACOs 'Gaming' Finances
. . .

Roundtable Members Submit Comments on Impact of 2017 Medicare Advantage Advance Notice

CMS has released a 45-day advance notice of the 2017 Medicare Advantage/Prescription Drug Plan proposed rates and benefit guidance. The expectation from the advance notice is for an overall increase in MA reimbursement. However, one provision, included in Section G, proposes to cut payments to Employer Group Waiver Plans (EGWP) for the 2017 calendar year.

Several Public Sector HealthCare Roundtable members have expressed concerns about how this reduction will affect their health benefits programs, and several are actively communicating their opposition to their congressional representatives. In addition, a number of members of Congress have expressed concerns regarding any cuts to MA.

We have included links to several of these letters for your information.

CMS comment letters
Congressional letters

Recent Roundtable Activity

April 6, 2017
Roundtable Supports Bill to Expand Development of Generic Drugs
"The bill would provide a clear solution to abusive, anticompetitive business practices that increase costs to the American health care system by impeding patient access to generic and biosimilar medicines."

Jan. 25, 2017
Roundtable Backs Move Toward Value-Based Care
"Through private and public sector alignment, the move toward value-based care is succeeding, measurably improving healthcare quality and contributing to historically low costs. Now is not the time for policymakers to signal a shift away from value-based care, either through action or inaction."

Sept. 27, 2016
Roundtable Seeks to Block Increases in Medicare Part B Premiums, Deductibles
"We are deeply concerned by the projected Part B premium and deductible increases, most notably for current and newly eligible beneficiaries living on low and fixed incomes. In 2014, half of the Medicare population lived on annual incomes of $24,150 or less. Newly enrolled Medicare beneficiaries, those not collecting Social Security benefits - many of whom are retired public servants - and state Medicaid programs should not be expected to carry the burden of paying for increased costs in Part B through higher premiums and cost sharing."

June 27, 2016
Roundtable Urges Lawmakers to Support Medicare Part B Payment Proposal
"Our support for the model is informed by our shared commitment to bipartisan efforts to transition Medicare from a volume-based system to one that reimburses based on health care quality and innovation."

June 14, 2016
Roundtable Backs Bill to Stop 'Anticompetitive' Practices by Brand Name Drug Companies
"The bill would provide a clear solution to abusive, anticompetitive business practices that increase costs to the American health care system by impeding patient access to generic medicines."

Jan. 28, 2016
Roundtable Submits Comments on Chronic Care Options Paper
"The Roundtable supports the efforts of the Working Group and believe the Policy Options Document reflects work and analysis that will further the goal of improving care for the millions of vulnerable Medicare beneficiaries managing multiple chronic conditions."

Dec. 21, 2015
Roundtable Backs REMS Reform to Promote Generic Drug Development
"[REMS] abuses are growing and the resulting delay in generic and biosimilars competition is costing patients, the federal government, and the health care system billions of dollars annually."

Oct. 27, 2015
Roundtable Urges FDA to Adopt Standard Names for Biosimilars
"All of the undersigned groups share the FDA's deep commitment to patient safety. As such, we strongly believe that biologics and biosimilars should be required to have the same International Nonproprietary Name (INN). The FDA's most recent proposal to add a suffix to traditional INNs is an unnecessary and unwise modifier."

Aug. 13, 2015
Roundtable Backs Generic Drug Availability in Letter to Senators
"As the HELP Committee continues its examination of the drug discovery and development process in the coming months, we urge you to maintain the important balance between access and innovation of Hatch-Waxman. We urge you not to include increases in exclusivity for brand manufacturers that would have the effect of burdening consumers, large and small businesses, and state and federal governments with unnecessary increased prescription drug costs through delayed generic and biosimilar entry."